← Leaderboards
Iqbal Ahmad
University Of Nebraska Medical Center
$5,936,094
Attributed
$5,936,094
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $923.7K · FY2013–22$1M$750K$500K$250K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$5,936,094 · 3
By mechanism
R01$5,936,094 · 3
Top collaborators
No co-investigators on record.
Most similar at University Of Nebraska Medical Center
Same institution · by research overlap
- Ram I Mahato$10,713,899
Others in their field
Top investigators on “Retina”
- Keri Hammel · The Emmes Company, Llc$53,700,408
- Krzysztof Palczewski · University Of California-Irvine$48,214,939
- Adam R Glassman · Jaeb Center For Health Research, Inc.$47,242,041
- Cecilia Sungmin Lee · University Of Washington$32,086,169
- Adam Glassman · Jaeb Center For Health Research, Inc.$31,583,813
- Karen J Cruickshanks · University Of Wisconsin Madison$28,499,261
Research focus
RetinaAffectSignal TransductionNatural RegenerationPathway InteractionsInduced Pluripotent Stem CellBlindnessRetinal Progenitor CellGlaucomaGenerationsRetinal Ganglion CellsBaseGenesAdultTransplantationIn VivoCellsPhysiologic Intraocular PressureNeuronsStem CellsLightAxon GrowthRetinal Ganglion Cell RegenerationRegenerative
Grant awards (18)
Human Disease Modeling of Glaucomatous Neuropathy$369,813
R01 · FY2022 · EY · contact PI
Induced pluripotent stem cell approach to optic nerve regeneration$369,813
R01 · FY2022 · EY · contact PI
Induced pluripotent stem cell approach to optic nerve regeneration$369,812
R01 · FY2021 · EY · contact PI
Human Disease Modeling of Glaucomatous Neuropathy$369,812
R01 · FY2021 · EY · contact PI
Induced pluripotent stem cell approach to optic nerve regeneration$381,250
R01 · FY2020 · EY · contact PI
Human Disease Modeling of Glaucomatous Neuropathy$381,250
R01 · FY2020 · EY · contact PI
Human Disease Modeling of Glaucomatous Neuropathy$161,245
R01 · FY2020 · EY · contact PI
Human Disease Modeling of Glaucomatous Neuropathy$381,250
R01 · FY2019 · EY · contact PI
Induced pluripotent stem cell approach to optic nerve regeneration$381,250
R01 · FY2019 · EY · contact PI
Induced pluripotent stem cell approach to optic nerve regeneration$381,042
R01 · FY2018 · EY · contact PI
Induced Pluripotent Stem Cell Approach to Glaucomatous Optic Neuropathy$371,250
R01 · FY2016 · EY · contact PI
Induced Pluripotent Stem Cell Approach to Glaucomatous Optic Neuropathy$363,825
R01 · FY2015 · EY · contact PI
Induced Pluripotent Stem Cell Approach to Glaucomatous Optic Neuropathy$363,825
R01 · FY2014 · EY · contact PI
Induced Pluripotent Stem Cell Approach to Glaucomatous Optic Neuropathy$371,250
R01 · FY2013 · EY · contact PI
Characterization of Ocular Neural Stem Cells$147,000
R01 · FY2004 · EY
Characterization of Ocular Neural Stem Cells$257,250
R01 · FY2003 · EY
Characterization of Ocular Neural Stem Cells$257,250
R01 · FY2002 · EY
Characterization of Ocular Neural Stem Cells$257,907
R01 · FY2001 · EY